FilingReader Intelligence

Fosun Pharma seeks approvals for bond issues, share repurchases

May 20, 2025 at 05:02 PM UTC•By FilingReader AI

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKEX: 2196) has announced plans to hold its Annual General Meeting (AGM) on June 24, 2025, seeking shareholder approval for a range of strategic resolutions. Key proposals include granting a general mandate to register and issue corporate bonds up to RMB6.0 billion, along with mandates to issue new A Shares and/or H Shares, and to repurchase existing A Shares and H Shares, each capped at 10% of the respective share class.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

ANNUAL GENERAL MEETING; GRANT OF GENERAL MANDATE TO REGISTER AND ISSUE CORPORATE BONDS; RENEWED AND ADDITIONAL GUARANTEE QUOTA; GRANT OF GENERAL MANDATE TO ISSUE A SHARES AND/OR H SHARES; GRANT OF GENERAL MANDATE TO REPURCHASE H SHARES; GRANT OF GENERAL MANDATE TO REPURCHASE A SHARES; CANCELLATION OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ITS APPENDICES; ELECTION OF THE NEW SESSION OF THE BOARD; NOTICE OF AGM AND NOTICE OF H SHAREHOLDERS CLASS MEETINGMay 20, 2025 at 08:47 AM UTC

Shanghai Fosun Pharmaceutical (Group) Co

HKEX:2196•Hong Kong Exchange

RSS feed for Shanghai Fosun Pharmaceutical (Group) Co

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical (Group) Co publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →